Back to Search Start Over

Supplementary Tables 1-3 from A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent

Authors :
Susan E. Bates
Jan H. Beumer
Edward Chu
Julie Eiseman
Chandra P. Belani
Yixing Jiang
David R. Kohler
Richard Piekarz
John J. Wright
William M. Bonner
Asako J. Nakamura
Christophe E. Redon
Christine Bryla
Robert A. Parise
Sanjeeve Balasubramaniam
Leonard J. Appleman
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Supplementary Tables 1-3. Supplemental Table 1. Plasma pharmacokinetics of DMS612 metabolites. Supplemental Table 2. Pharmacodynamic assessment of !-H2AX detection in PBMCs. Mean values for !-H2AX foci per cell with DMS612 doses of 1.5, 3, 5, 7, 9 and 12 mg/m2 at the indicated time in hours (h). Supplemental Table 3. Pharmacodynamic assessment of !-H2AX detection in hair follicles. Mean values for cell with more than 4 !-H2AX foci per cell in plucked scalp hairs with DMS612 doses of 1.5, 3 and 9 mg/m2 at the indicated time in hours (h).

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....6acbe4e4740497e7dc390afc20e3a505